Disclosed positions

Estimated from their latest filings — positions may have changed since

$765.6K

combined est. value

Stock	Shares	Price	Value	Weight	As of
AGIOAGIOS PHARMACEUTICALS, INC.	10,865	$42.76	$464.6K	61%	2026-06-18
NEOGNEOGEN CORP	32,502	$9.26	$301.0K	39%	2025-10-27

AGIO

AGIOS PHARMACEUTICALS, INC.

$464.6K

10,865 sh

NEOG

NEOGEN CORP

$301.0K

32,502 sh

All filings on record

Every Form 4 transaction we track for this filer

all 7buys 0sells 0

Stock	Transaction	Date	~6mo later
AGIOAGIOS PHARMACEUTICALS, INC.	Exercise — · 2,816 sh	2026-06-18	—
NEOGNEOGEN CORP	Exercise $11.0K · 1,777 sh	2025-10-27	—
NEOGNEOGEN CORP	Exercise $12.5K · 2,025 sh	2025-10-27	—
NEOGNEOGEN CORP	Grant $120.0K · 19,769 sh	2025-10-23	—
NEOGNEOGEN CORP	Exercise $11.7K · 2,071 sh	2025-10-07	—
AGIOAGIOS PHARMACEUTICALS, INC.	Exercise — · 2,120 sh	2025-06-20	—
AGIOAGIOS PHARMACEUTICALS, INC.	Exercise — · 1,977 sh	2025-06-13	—

AGIOExercise

2026-06-18 · AGIOS PHARMACEUTICALS, INC.

2,816

—

NEOGExercise

2025-10-27 · NEOGEN CORP

$11.0K

—

NEOGExercise

2025-10-27 · NEOGEN CORP

$12.5K

—

NEOGGrant

2025-10-23 · NEOGEN CORP

$120.0K

—

NEOGExercise

2025-10-07 · NEOGEN CORP

$11.7K

—

AGIOExercise

2025-06-20 · AGIOS PHARMACEUTICALS, INC.

2,120

—

AGIOExercise

2025-06-13 · AGIOS PHARMACEUTICALS, INC.

1,977

—

Outcomes measure each disclosed buy against the closing price ~6 months (120 trading days) later, with the S&P 500 over the same span for context. Pre-scheduled 10b5-1 plan trades are excluded from the record. Positions are estimated from the latest reported post-transaction holdings, split-adjusted, at the latest close. Built from SEC Form 4 filings and market prices — past outcomes, not predictions or advice.